The paper discusses the sympathomimetic actions of beta-aminopropylbenzene (benzedrine), including its effects on blood pressure and cardiac standstill.
No takes yet. Share an insight, caveat, or question.
Alerts clinicians to sympathomimetic cardiovascular risks; leaves open updated safety assessments for amphetamine derivatives.
M. H. Nathanson (1937) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: